PPT-Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention

Results from the FAME 2 trial William Fearon Bernard De Bruyne Nico Pijls David Shilane Derek Boothroyd Pim Tonino Emmanuele Barbato Peter Juni. Vlaar MD P D Karim D Mahmoud BS David R Holmes J MD P D Gert van Valkenhoef MS57511 Hans L Hillege MD P D57511 Iwan C C van der Horst MD P D Felix Zijlstra MD P D57511 Bart J G L de Smet MD P D Groningen and Rotterdam the Netherlands and Rochester lufwanyama. neonatal survival study. Christopher J. Gill MD MS. Center for Global Health and Development. Department of International Health. Boston University School of Public Health. ICIUM 2012, Antalya Turkey. Edward Broughton, PhD, MPH, PT. University Research Co.. May 21 . , 2014. ebroughton@urc-chs.com. Your decision….. 2. What would you pay? . . An . error . while. splinting . wrist . fractures . can cause pain in the 5. Decompression: . An . Innovative Treatment for LSS. Sayed . Emal. . Wahezi. , MD. Program Director, Pain Fellowship. Department of Rehabilitation Medicine. Department of Anesthesia. Montefiore Medical Center. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Key points. The term acute coronary syndrome describes the. bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. coronary intervention – . summary of key articles. Prepared by Radcliffe Cardiology. 21 November2016. Abbreviations. CABG: . coronary artery bypass grafting. CAD: . coronary artery disease. FFR: . fractional flow reserve. Impact of regionalization of ST elevation myocardial infarction care on treatment times and outcomes for emergency medical services transported patients presenting to hospitals with percutaneous coronary intervention J . Kruger. 1. , . A . Brennan. 1. , . P . Thokala. 1. , . S . Heller. 2. . on behalf of the DAFNE Research Group. 1 School of Health and Related Research (ScHARR), University of Sheffield, Sheffield. . 2021 ACC/AHA/SCAI Guideline of Coronary Artery Revascularization. Table 1. . Applying. . ACC/AHA Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care . ROSI AMRILLA F, MD. INTRODUCTION. Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque in the epicardial arteries, whether obstructive or non-obstructive. Anatomical the coronary artery lumen and wall can be evaluated by Coronary CT Angiography (coronary CTA) and Invasive Coronary Angiography (ICA). 108 Instituto de Cardiologia do Rio Grande do Sul, Fundação Universitária de Cardiologia – (IC/FUC) Porto Alegre (RS), Brazil.Programa de Pós Graduação em Ciências da Saúde: Cardiologia/ Intravascular Ultrasound . to Guide Percutaneous Coronary Intervention. . The FLAVOUR trial. Bon-Kwon Koo, MD, PhD. Seoul National University Hospital, Seoul, . Republic of Korea. Bon-Kwon Koo, MD, PhD. Lyndon C. Box, MD FSCAI. West Valley Cardiology, Caldwell ID. On behalf of the authors, SCAI Executive Committee and the SCAI Government Relations Committee. Disclosures. NONE. Why?. Centers for Medicaid and Medicare Services, .